In 'golden age' for CDMOs, Thermo Fisher invests $150M in pharma services unit

In 'golden age' for CDMOs, Thermo Fisher invests $150M in pharma services unit

Source: 
Biopharma Dive
snippet: 

The lab and instruments giant has expanded in the contract pharma and biotech markets following a multi-billion dollar deal for Patheon two years ago.